NEW YORK, Sept. 20, 2023 /PRNewswire/ The biobanking market is expected to grow by USD 1.45 billion from 2022 to 2027. In addition, the market's momentum will progress at a CAGR of 8.58% during the forecast
/PRNewswire/ The biobanking market is expected to grow by USD 1.45 billion from 2022 to 2027. In addition, the market s momentum will progress at a CAGR of.
The biobanking market is expected to grow by USD 1.45 billion from 2022 to 2027. In addition, the market's momentum will progress at a CAGR of 8.58% during the forecast period, according to Technavio Research. The market is segmented by Type (Physical and Virtual), Product (Equipment and Consumables), and Geography (Europe, North America, Asia, and the Rest of the World (ROW)). Europe is estimated to contribute 38% to the growth of the global market during the forecast period. A growing need for
During the forecast period, the pancreatic stone protein testing market is expected to grow at a rapid 1.8% CAGR. The pancreatic stone protein testing market is currently valued at US$ 3 billion in 2022, with a projected value of US$ 3.59 billion by 2032.Different pancreatic secretory proteins have been identified i.